This HTML5 document contains 149 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-shhttp://sh.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
dbpedia-huhttp://hu.dbpedia.org/resource/
n34https://global.dbpedia.org/id/
umbel-rchttp://umbel.org/umbel/rc/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n14http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
dbpedia-srhttp://sr.dbpedia.org/resource/
dbpedia-plhttp://pl.dbpedia.org/resource/
dbpedia-pthttp://pt.dbpedia.org/resource/
n24https://druginfo.nlm.nih.gov/drugportal/name/
dbpedia-fihttp://fi.dbpedia.org/resource/
n26http://azb.dbpedia.org/resource/
n19http://commons.wikimedia.org/wiki/Special:FilePath/
dbpedia-fahttp://fa.dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
dbpedia-arhttp://ar.dbpedia.org/resource/
owlhttp://www.w3.org/2002/07/owl#
dbpedia-vihttp://vi.dbpedia.org/resource/
dbpedia-ithttp://it.dbpedia.org/resource/
dbpedia-frhttp://fr.dbpedia.org/resource/
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Deferiprone
rdf:type
yago:WikicatChelatingAgents yago:Antidote102719588 dbo:ChemicalSubstance n14:ChemicalObject owl:Thing yago:Matter100020827 yago:Agent114778436 umbel-rc:DrugProduct yago:Medicine103740161 dbo:Drug yago:Substance100020090 yago:WikicatAntidotes yago:Agent109190918 yago:PhysicalEntity100001930 wikidata:Q8386 yago:Drug103247620 yago:Remedy104074482 yago:CausalAgent100007347
rdfs:label
Deferiprone Deferiprona Défériprone ديفيريبرون Deferiprone Deferypron
rdfs:comment
Il deferiprone è un principio attivo che agisce come ferrochelante; esso è indicato secondo l'RCP nel trattamento dell'accumulo di ferro (emosiderosi) nei pazienti affetti da talassemia maggiore, quando la terapia con deferoxamina è controindicata o non adeguata. Il farmaco è stato studiato dalla ApoPharma. In Italia è commercializzato dalla Chiesi Farmaceutici dal 1999, con il nome: Ferriprox. ديفيريبرون هو دواء يتمخلب بالحديد ويستعمل في علاج التحميل المفرط للحديد في الثلاسيمية الكبرى. رخص استعماله أول مرة في علاج الثلاسيمية الكبرى في عام 1994 وقد حصل على الترخيص أولا في أوروبا وآسيا لكنه انتظر سنوات عديدة قبل ترخيصه في كندا والولايات المتحدة. ففي 14 أكتوبر 2011, حصل على موافقة في الولايات المتحدة تحت لإدارة الغذاء والدواء. Deferiprona, também conhecido pelo nome comercial Ferriprox, é um fármaco usado como agente quelante do ferro. É usado no tratamento de talassemia. A deferiprona é um tratamento alternativo para a sobrecarga de ferro em pacientes com talassemia major incapazes de receber a desferroxamina. Deferypron (łac. Deferipronum) – związek chelatujący żelazo, stosowany w leczeniu talasemii. Le défériprone est une molécule chélatrice du fer, utilisé comme médicament dans les surcharges en fer. Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major. It was first approved and indicated for use in treating thalassaemia major in 1994 and had been licensed for use in the European Union for many years while awaiting approval in Canada and in the United States. On October 14, 2011, it was approved for use in the US under the FDA's accelerated approval program.
foaf:depiction
n19:Deferiprone.svg
dcterms:subject
dbc:Chelating_agents dbc:Antidotes dbc:4-Pyridones dbc:Chelating_agents_used_as_drugs
dbo:wikiPageID
9494348
dbo:wikiPageRevisionID
1105534631
dbo:wikiPageWikiLink
dbc:Chelating_agents dbr:Oral_administration dbr:Kidney dbr:Hepatic_fibrosis dbr:Apotex dbr:Haematologist dbc:Antidotes dbr:FDA dbr:Thalassaemia dbr:Thalassaemia_major dbr:Nancy_Olivieri dbr:Chelate dbr:Researcher dbr:Medication dbr:The_Hospital_for_Sick_Children,_Toronto dbr:Accelerated_approval_(FDA) dbr:Pharmaceutical_company dbr:Iron dbr:Glucuronidation dbc:4-Pyridones dbc:Chelating_agents_used_as_drugs
dbo:wikiPageExternalLink
n24:deferiprone
owl:sameAs
dbpedia-it:Deferiprone dbpedia-vi:Deferiprone dbpedia-sh:Deferipron dbpedia-hu:Deferipron dbpedia-ar:ديفيريبرون dbpedia-sr:Deferipron freebase:m.028c5_t wikidata:Q749664 n26:دفریپرون dbpedia-pt:Deferiprona dbpedia-fi:Deferiproni dbpedia-fr:Défériprone dbpedia-fa:دفریپرون yago-res:Deferiprone dbpedia-pl:Deferypron n34:4upsd
dbp:wikiPageUsesTemplate
dbt:Cite_web dbt:Drugbankcite dbt:Keggcite dbt:Chemspidercite dbt:Short_description dbt:Cascite dbt:Infobox_drug dbt:Chelating_agents dbt:Fdacite dbt:Drugs.com dbt:Reflist dbt:Portal_bar dbt:Stdinchicite dbt:Ebicite
dbo:thumbnail
n19:Deferiprone.svg?width=300
dbp:atcSuffix
AC02
dbp:atcPrefix
V03
dbp:c
7
dbp:casNumber
30652
dbp:chebi
68554
dbp:chembl
70927
dbp:chemspiderid
2866
dbp:drugbank
DB08826
dbp:eliminationHalfLife
10800.0
dbp:excretion
dbr:Kidney
dbp:h
9
dbp:iupacName
3
dbp:kegg
D07416
dbp:legalStatus
Rx-only
dbp:legalUk
POM
dbp:legalUs
Rx-only
dbp:medlineplus
a612016
dbp:metabolism
dbr:Glucuronidation
dbp:n
1
dbp:o
2
dbp:pregnancyUs
D
dbp:pubchem
2972
dbp:routesOfAdministration
dbr:Oral_administration
dbp:smiles
O=C\1C=CC
dbp:stdinchi
1
dbp:stdinchikey
TZXKOCQBRNJULO-UHFFFAOYSA-N
dbp:tradename
Ferriprox
dbp:unii
2
dbp:verifiedfields
changed
dbp:verifiedrevid
443270530
dbp:watchedfields
changed
dbp:width
120
dbo:abstract
Deferiprona, também conhecido pelo nome comercial Ferriprox, é um fármaco usado como agente quelante do ferro. É usado no tratamento de talassemia. A deferiprona é um tratamento alternativo para a sobrecarga de ferro em pacientes com talassemia major incapazes de receber a desferroxamina. Deferypron (łac. Deferipronum) – związek chelatujący żelazo, stosowany w leczeniu talasemii. Il deferiprone è un principio attivo che agisce come ferrochelante; esso è indicato secondo l'RCP nel trattamento dell'accumulo di ferro (emosiderosi) nei pazienti affetti da talassemia maggiore, quando la terapia con deferoxamina è controindicata o non adeguata. Il farmaco è stato studiato dalla ApoPharma. In Italia è commercializzato dalla Chiesi Farmaceutici dal 1999, con il nome: Ferriprox. Le défériprone est une molécule chélatrice du fer, utilisé comme médicament dans les surcharges en fer. Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major. It was first approved and indicated for use in treating thalassaemia major in 1994 and had been licensed for use in the European Union for many years while awaiting approval in Canada and in the United States. On October 14, 2011, it was approved for use in the US under the FDA's accelerated approval program. The most common side effects include red-brown urine (showing that iron is being removed through the urine), nausea (feeling sick), abdominal pain (stomach ache) and vomiting. Less common but more serious side effects are agranulocytosis (very low levels of granulocytes, a type of white blood cell) and neutropenia (low levels of neutrophils, a type of white blood cell that fights infections). ديفيريبرون هو دواء يتمخلب بالحديد ويستعمل في علاج التحميل المفرط للحديد في الثلاسيمية الكبرى. رخص استعماله أول مرة في علاج الثلاسيمية الكبرى في عام 1994 وقد حصل على الترخيص أولا في أوروبا وآسيا لكنه انتظر سنوات عديدة قبل ترخيصه في كندا والولايات المتحدة. ففي 14 أكتوبر 2011, حصل على موافقة في الولايات المتحدة تحت لإدارة الغذاء والدواء.
dbp:dailymedid
Deferiprone
dbp:iupharLigand
7456
dbp:legalAu
S4
dbp:legalEu
Rx-only
dbp:legalUkComment
/ P
dbp:licenceEu
yes
dbp:licenceUs
Deferiprone
dbp:pregnancyAu
D
gold:hypernym
dbr:Drug
prov:wasDerivedFrom
wikipedia-en:Deferiprone?oldid=1105534631&ns=0
dbo:wikiPageLength
10209
dbo:alternativeName
Ferriprox
dbo:casNumber
30652-11-0
dbo:chEBI
68554
dbo:chEMBL
70927
dbo:drugbank
DB08826
dbo:fdaUniiCode
2BTY8KH53L
dbo:kegg
D07416
dbo:medlinePlus
a612016
dbo:pubchem
2972
foaf:isPrimaryTopicOf
wikipedia-en:Deferiprone